Circulating annexin A2 as a biomarker in patients with pancreatic cancer
Conclusions: AnxA2 is identified as a novel secretory biomarker for PC, but it has no role as a prognostic or predictive marker.
Source: Journal of Cancer Research and Therapeutics - Category: Cancer & Oncology Authors: Mehmet Karabulut Cigdem Usul Afsar Murat Serilmez Senem Karabulut Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Liver | Palliative | Pancreas | Pancreatic Cancer | Statistics | Study | Urology & Nephrology